Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bayesian adaptive dose-finding study of intravenous GSK315234A in active rheumatoid arthritis
2006-000923-32Phase 2Terminated
- Sponsor
- GSK
- Start
- Oct 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing GSK315234A intravenous infusion with Placebo intravenous infusion (2 arms). Primary endpoint: Safety assessments. Started Oct 2007; status: terminated.
02
Drugs
GSK315234
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-000923-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000923-32.